These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 8825195

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog.
    Shukla UA, Marathe PH, Pittman KA, Barbhaiya RH.
    Drug Metab Dispos; 1993; 21(3):502-7. PubMed ID: 8100508
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Absorption and presystemic metabolism of nefazodone administered at different regions in the gastrointestinal tract of humans.
    Marathe PH, Salazar DE, Greene DS, Brennan J, Shukla UA, Barbhaiya RH.
    Pharm Res; 1995 Nov; 12(11):1716-21. PubMed ID: 8592675
    [Abstract] [Full Text] [Related]

  • 5. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
    Kaul S, Shyu WC, Shukla UA, Dandekar KA, Barbhaiya RH.
    Drug Metab Dispos; 1993 Nov; 21(3):447-53. PubMed ID: 8100500
    [Abstract] [Full Text] [Related]

  • 6. Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans.
    Vyas KP, Halpin RA, Geer LA, Ellis JD, Liu L, Cheng H, Chavez-Eng C, Matuszewski BK, Varga SL, Guiblin AR, Rogers JD.
    Drug Metab Dispos; 2000 Jan; 28(1):89-95. PubMed ID: 10611145
    [Abstract] [Full Text] [Related]

  • 7. A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses.
    Barbhaiya RH, Buch AB, Greene DS.
    J Clin Psychopharmacol; 1996 Feb; 16(1):19-25. PubMed ID: 8834414
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [Abstract] [Full Text] [Related]

  • 9. Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation.
    Barbhaiya RH, Shukla UA, Chaikin P, Greene DS, Marathe PH.
    Eur J Clin Pharmacol; 1996 Jan; 50(1-2):101-7. PubMed ID: 8739819
    [Abstract] [Full Text] [Related]

  • 10. Disposition of oral [14C]cefcanel daloxate hydrochloride in healthy male subjects.
    Edwall B, Arvidsson A, Lake-Bakaar D, Lanbeck-Vallén K, Yisak W.
    Drug Metab Dispos; 1993 Jan; 21(1):171-7. PubMed ID: 8095213
    [Abstract] [Full Text] [Related]

  • 11. Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan.
    Barbhaiya RH, Buch AB, Greene DS.
    Br J Clin Pharmacol; 1996 Nov; 42(5):573-81. PubMed ID: 8951188
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.
    Mayol RF, Cole CA, Luke GM, Colson KL, Kerns EH.
    Drug Metab Dispos; 1994 Nov; 22(2):304-11. PubMed ID: 8013286
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of ethylene glycol. II. Tissue distribution, dose-dependent elimination, and identification of urinary metabolites following single intravenous, peroral or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
    Frantz SW, Beskitt JL, Grosse CM, Tallant MJ, Dietz FK, Ballantyne B.
    Xenobiotica; 1996 Nov; 26(11):1195-220. PubMed ID: 8948094
    [Abstract] [Full Text] [Related]

  • 14. Disposition of [14C]avitriptan in rats and humans.
    Marathe PH, Greene DS, Barbhaiya RH.
    Drug Metab Dispos; 1997 Jul; 25(7):881-8. PubMed ID: 9224783
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice.
    Frantz SW, Beskitt JL, Grosse CM, Tallant MJ, Dietz FK, Ballantyne B.
    Drug Metab Dispos; 1996 Aug; 24(8):911-21. PubMed ID: 8869828
    [Abstract] [Full Text] [Related]

  • 16. Disposition and metabolism of finasteride in dogs.
    Carlin JR, Christofalo P, Arison BH, Ellsworth RE, Rosegay A, Miller RR, Chiu SH, VandenHeuvel WJ.
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [Abstract] [Full Text] [Related]

  • 17. Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteers.
    Polsky-Fisher SL, Vickers S, Cui D, Subramanian R, Arison BH, Agrawal NG, Goel TV, Vessey LK, Murphy MG, Lasseter KC, Simpson RC, Vega JM, Rodrigues AD.
    Drug Metab Dispos; 2006 Jun; 34(6):1004-11. PubMed ID: 16510541
    [Abstract] [Full Text] [Related]

  • 18. Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment.
    Barbhaiya RH, Shukla UA, Greene DS.
    Eur J Clin Pharmacol; 1995 Jun; 49(3):221-8. PubMed ID: 8665999
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of nefazodone following multiple escalating oral doses in the dog.
    Shukla UA, Kaul S, Marathe PH, Pittman KA, Barbhaiya RH.
    Eur J Drug Metab Pharmacokinet; 1992 Jun; 17(4):309-18. PubMed ID: 1301361
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous quantitation of d7-nefazodone, nefazodone, d7-hydroxynefazodone, hydroxynefazodone, m-chlorophenylpiperazine and triazole-dione in human plasma by liquid chromatographic-mass spectrometry.
    Yao M, Srinivas NR.
    Biomed Chromatogr; 2000 Apr; 14(2):106-12. PubMed ID: 10694704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.